scorecardresearch
Follow Us:
Friday, September 17, 2021

Covovax

COVOVAX NEWS

Govt panel recommends nod to SII for phase 2/3 trials of Covovax on children aged 2-17

July 27, 2021 10:39 pm

The trials would cover 920 children, 460 each in the age-group of 12-17 and 2-11 across 10 sites.

Mumbai: City hospitals to soon start trials of new Serum vaccine and ZyCoV-D for children

August 25, 2021 11:28 pm

Covovax, manufactured by Serum Institute of India, will undergo a Phase II/III trial to measure safety and immune response across 20 hospital sites. Of those, eight sites are in Maharashtra.

Now, Serum to apply for DCGI approval for clinical trial of Covovax on children

June 26, 2021 7:57 am

Covovax is the second Covid-19 vaccine candidate, which is being developed and manufactured at Pune-based SII.

Serum could begin Covovax trial on children in India next month

June 18, 2021 11:30 am

The recombinant nanoparticle protein-based vaccine — NVX-CoV2373 — developed by the American biotechnology firm has been branded Covovax in India.

Covovax Phase 3 trial to proceed without placebo as DCGI gives nod to revised protocol

June 06, 2021 8:08 am

Under a placebo-controlled trial, some volunteers are administered the drug while some are given a placebo to help researchers compare and understand the efficacy of the medication.

Second Serum Institute vaccine set for phase-3 clinical trial by mid-May

May 04, 2021 7:15 am

The Data Safety Monitoring Board has reviewed the initial safety data of 200 participants of phase-2 clinical trial of Covovax and has given its recommendation. The Drugs Controller General of India has given the go-ahead for a larger phase-3 trial.

Explained: Why does India need Covid-19 vaccine ingredients from US?

April 30, 2021 8:35 am

The CEO of Serum Institute of India has urged President Joe Biden to lift the US embargo on export of vaccine raw materials. How important are these raw materials to vaccine manufacturers in India and other countries?